IRON · Disc Medicine, Inc.
$65.46
-0.41 (-0.62%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$2.50B
Shares
38.39M
Volume · Sep 30
671.49K
Avg daily vol (3M)
481.57K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$65.46
Open$66.08
Day$64.24–66.08
52W close$55.95–94.11
Avg vol 30d531K
Short int7.2M · 18.8% float · 13.6d
Short vol61%
Last earningsJul 30, 2026
DataAug 2020–Sep 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 19, 2026
Est · unconfirmed
· in 3 wks
filed Jul 30, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$245.89M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-7.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+10.5%
Year over year · more shares
Price change (1Y)
+1.2%
Trailing year
Short interest
18.8%
Latest settlement · 13.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−9%
below
Price vs 50-day avg
−13%
below
RSI (14)
29
oversold
MACD trend
Negative
52-week position
25%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−17%
trailing
6-month return
−3%
trailing
YTD return
−18%
this year
Relative strength
−15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $75 › 200d $72 — 50d above 200d
Institutional flow
Accumulating
+8% holders QoQ · +40 funds added
Insider flow
Distributing
Net -$1.9M over 90 days · 100% sells
Short interest
Falling
18.77% of float · ▼ -2.1% MoM · 13.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
222 holders — near 3-yr high, broad support
Squeeze score
69
elevated · 0–100
Fundamentals
EPS growth
−52%
Y/Y
Free cash flow
$-181.3M
Balance sheet
$62.0M
net cash
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
4.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−9%
Bearish
Price vs 50-day avg
−13%
Bearish
RSI (14)
29
Neutral
MACD trend
Negative
Bearish
52-week position
25%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $75 › 200d $72 — 50d above 200d
Institutional flow
Accumulating
+8% holders QoQ · +40 funds added
Insider flow
Distributing
Net -$1.9M over 90 days · 100% sells
Short interest
Falling
18.77% of float · ▼ -2.1% MoM · 13.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
222 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $56
Now $65 · 25%
Range high $94
vs 200-day avg -9%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IRON
this stock
Disc Medicine, Inc.
|
$2.50B | -17.6% | — | — | 18.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +15.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -1.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +553.0% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IRON | -1.0% | -16.8% | -2.7% | -16.8% | -17.6% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -0.3% | -16.9% | -14.9% | -16.2% | -29.4% |